N-[[3-[(3-cyclopropyl-1,2,4-triazol-1-yl)sulfonyl]phenyl]methyl]-1-[4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-7-(8-ethynyl-7-fluoronaphthalen-1-yl)-8-fluoropyrido[4,3-d]pyrimidin-2-yl]-N-methylazetidin-3-amine

C41H38F2N10O2S — CID 176937642

IUPACN-[[3-[(3-cyclopropyl-1,2,4-triazol-1-yl)sulfonyl]phenyl]methyl]-1-[4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-7-(8-ethynyl-7-fluoronaphthalen-1-yl)-8-fluoropyrido[4,3-d]pyrimidin-2-yl]-N-methylazetidin-3-amine
SMILESC#Cc1c(F)ccc2cccc(-c3ncc4c(N5CC6CCC(C5)N6)nc(N5CC(N(C)Cc6cccc(S(=O)(=O)n7cnc(C8CC8)n7)c6)C5)nc4c3F)c12
InChIInChI=1S/C41H38F2N10O2S/c1-3-31-34(42)15-12-25-7-5-9-32(35(25)31)37-36(43)38-33(17-44-37)40(51-19-27-13-14-28(20-51)46-27)48-41(47-38)52-21-29(22-52)50(2)18-24-6-4-8-30(16-24)56(54,55)53-23-45-39(49-53)26-10-11-26/h1,4-9,12,15-17,23,26-29,46H,10-11,13-14,18-22H2,2H3
InChIKeyZOOKYTDDLFIDNF-UHFFFAOYSA-N
MW772.89 g/mol
LogP5.07
Rot. Bonds9

About N-[[3-[(3-cyclopropyl-1,2,4-triazol-1-yl)sulfonyl]phenyl]methyl]-1-[4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-7-(8-ethynyl-7-fluoronaphthalen-1-yl)-8-fluoropyrido[4,3-d]pyrimidin-2-yl]-N-methylazetidin-3-amine

N-[[3-[(3-cyclopropyl-1,2,4-triazol-1-yl)sulfonyl]phenyl]methyl]-1-[4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-7-(8-ethynyl-7-fluoronaphthalen-1-yl)-8-fluoropyrido[4,3-d]pyrimidin-2-yl]-N-methylazetidin-3-amine (PubChem CID 176937642) has the molecular formula C41H38F2N10O2S and a molecular weight of 772.89 g/mol. Its IUPAC name is N-[[3-[(3-cyclopropyl-1,2,4-triazol-1-yl)sulfonyl]phenyl]methyl]-1-[4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-7-(8-ethynyl-7-fluoronaphthalen-1-yl)-8-fluoropyrido[4,3-d]pyrimidin-2-yl]-N-methylazetidin-3-amine.

Molecular Properties

Compound NameN-[[3-[(3-cyclopropyl-1,2,4-triazol-1-yl)sulfonyl]phenyl]methyl]-1-[4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-7-(8-ethynyl-7-fluoronaphthalen-1-yl)-8-fluoropyrido[4,3-d]pyrimidin-2-yl]-N-methylazetidin-3-amine
PubChem CID176937642
Molecular FormulaC41H38F2N10O2S
Molecular Weight772.89 g/mol
Exact Mass772.29
IUPAC NameN-[[3-[(3-cyclopropyl-1,2,4-triazol-1-yl)sulfonyl]phenyl]methyl]-1-[4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-7-(8-ethynyl-7-fluoronaphthalen-1-yl)-8-fluoropyrido[4,3-d]pyrimidin-2-yl]-N-methylazetidin-3-amine
SMILESC#Cc1c(F)ccc2cccc(-c3ncc4c(N5CC6CCC(C5)N6)nc(N5CC(N(C)Cc6cccc(S(=O)(=O)n7cnc(C8CC8)n7)c6)C5)nc4c3F)c12
InChIInChI=1S/C41H38F2N10O2S/c1-3-31-34(42)15-12-25-7-5-9-32(35(25)31)37-36(43)38-33(17-44-37)40(51-19-27-13-14-28(20-51)46-27)48-41(47-38)52-21-29(22-52)50(2)18-24-6-4-8-30(16-24)56(54,55)53-23-45-39(49-53)26-10-11-26/h1,4-9,12,15-17,23,26-29,46H,10-11,13-14,18-22H2,2H3
InChIKeyZOOKYTDDLFIDNF-UHFFFAOYSA-N
XLogP5.07
TPSA125.27 Ų
H-Bond Donors1
H-Bond Acceptors12
Rotatable Bonds9
Heavy Atoms56
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500772.89
LogP ≤ 55.07
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze N-[[3-[(3-cyclopropyl-1,2,4-triazol-1-yl)sulfonyl]phenyl]methyl]-1-[4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-7-(8-ethynyl-7-fluoronaphthalen-1-yl)-8-fluoropyrido[4,3-d]pyrimidin-2-yl]-N-methylazetidin-3-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[[3-[(3-cyclopropyl-1,2,4-triazol-1-yl)sulfonyl]phenyl]methyl]-1-[4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-7-(8-ethynyl-7-fluoronaphthalen-1-yl)-8-fluoropyrido[4,3-d]pyrimidin-2-yl]-N-methylazetidin-3-amine?
The IUPAC name of N-[[3-[(3-cyclopropyl-1,2,4-triazol-1-yl)sulfonyl]phenyl]methyl]-1-[4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-7-(8-ethynyl-7-fluoronaphthalen-1-yl)-8-fluoropyrido[4,3-d]pyrimidin-2-yl]-N-methylazetidin-3-amine (CID 176937642) is N-[[3-[(3-cyclopropyl-1,2,4-triazol-1-yl)sulfonyl]phenyl]methyl]-1-[4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-7-(8-ethynyl-7-fluoronaphthalen-1-yl)-8-fluoropyrido[4,3-d]pyrimidin-2-yl]-N-methylazetidin-3-amine.
What is the SMILES notation for N-[[3-[(3-cyclopropyl-1,2,4-triazol-1-yl)sulfonyl]phenyl]methyl]-1-[4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-7-(8-ethynyl-7-fluoronaphthalen-1-yl)-8-fluoropyrido[4,3-d]pyrimidin-2-yl]-N-methylazetidin-3-amine?
The canonical SMILES for N-[[3-[(3-cyclopropyl-1,2,4-triazol-1-yl)sulfonyl]phenyl]methyl]-1-[4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-7-(8-ethynyl-7-fluoronaphthalen-1-yl)-8-fluoropyrido[4,3-d]pyrimidin-2-yl]-N-methylazetidin-3-amine is C#Cc1c(F)ccc2cccc(-c3ncc4c(N5CC6CCC(C5)N6)nc(N5CC(N(C)Cc6cccc(S(=O)(=O)n7cnc(C8CC8)n7)c6)C5)nc4c3F)c12.
What is the InChIKey of N-[[3-[(3-cyclopropyl-1,2,4-triazol-1-yl)sulfonyl]phenyl]methyl]-1-[4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-7-(8-ethynyl-7-fluoronaphthalen-1-yl)-8-fluoropyrido[4,3-d]pyrimidin-2-yl]-N-methylazetidin-3-amine?
The InChIKey is ZOOKYTDDLFIDNF-UHFFFAOYSA-N. The full InChI is InChI=1S/C41H38F2N10O2S/c1-3-31-34(42)15-12-25-7-5-9-32(35(25)31)37-36(43)38-33(17-44-37)40(51-19-27-13-14-28(20-51)46-27)48-41(47-38)52-21-29(22-52)50(2)18-24-6-4-8-30(16-24)56(54,55)53-23-45-39(49-53)26-10-11-26/h1,4-9,12,15-17,23,26-29,46H,10-11,13-14,18-22H2,2H3.
What are the key properties of N-[[3-[(3-cyclopropyl-1,2,4-triazol-1-yl)sulfonyl]phenyl]methyl]-1-[4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-7-(8-ethynyl-7-fluoronaphthalen-1-yl)-8-fluoropyrido[4,3-d]pyrimidin-2-yl]-N-methylazetidin-3-amine?
N-[[3-[(3-cyclopropyl-1,2,4-triazol-1-yl)sulfonyl]phenyl]methyl]-1-[4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-7-(8-ethynyl-7-fluoronaphthalen-1-yl)-8-fluoropyrido[4,3-d]pyrimidin-2-yl]-N-methylazetidin-3-amine has a molecular weight of 772.89 g/mol, XLogP of 5.07, 9 rotatable bonds, 1 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[3-[(3-cyclopropyl-1,2,4-triazol-1-yl)sulfonyl]phenyl]methyl]-1-[4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-7-(8-ethynyl-7-fluoronaphthalen-1-yl)-8-fluoropyrido[4,3-d]pyrimidin-2-yl]-N-methylazetidin-3-amine is sourced from PubChem (CID 176937642), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).